Healthcare Global Enterprises' Q1 FY 2025-26 Quarterly Results

Result Summary

• Healthcare Global Enterprises Ltd reported a 24.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 16.0%.
• Its expenses for the quarter were up by 28.0% QoQ and 18.1% YoY.
• The net profit decreased 74.5% QoQ and decreased 56.1% YoY.
• The earnings per share (EPS) of Healthcare Global Enterprises Ltd stood at 0.3 during Q1 FY 2025-26.

Financial Statments for Q1 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Healthcare Global Enterprises Ltd (HCG) is a prominent player in the healthcare industry, primarily focused on providing cancer care. The company operates a network of cancer centers across India and offers a comprehensive range of oncology services, including diagnostics, chemotherapy, and advanced cancer treatments. HCG is known for its expertise in radiation therapy and robotic surgery, contributing significantly to its reputation as a leader in cancer care. While specific recent developments are not available, the company is generally considered a significant entity in the healthcare sector, continually expanding its reach and services to address the growing demand for specialized cancer treatments.

Revenue

For the first quarter of fiscal year 2026 (Q1FY26), Healthcare Global Enterprises Ltd reported a total income of ₹619.99 crores. This represents a 24.1% increase compared to the previous quarter (Q4FY25), where the total income was ₹499.68 crores. Year-over-year, the total income grew by 16.0% from ₹534.39 crores in Q1FY25. This upward trend in revenue may reflect the company's continued expansion and increased patient footfall in its cancer centers. The revenue growth aligns with the company's strategic focus on enhancing its service offerings and geographic presence to capture a larger share of the healthcare market.

Profitability

The profitability metrics for Healthcare Global Enterprises Ltd during Q1FY26 show a varied performance. The profit before tax (PBT) for the quarter was ₹11.24 crores, a significant decrease of 60.1% from ₹28.16 crores in Q4FY25. This also marked a 40.8% decline compared to ₹19.00 crores in Q1FY25. The profit after tax (PAT) stood at ₹5.98 crores, representing a 74.5% quarter-over-quarter decrease from ₹23.46 crores in Q4FY25, and a 56.1% year-over-year decrease from ₹13.63 crores in Q1FY25. The tax for Q1FY26 was ₹5.94 crores, reflecting a 24.8% increase from the previous quarter and a 10.8% increase year-over-year. Earnings per share (EPS) were ₹0.30, down from ₹1.50 in Q4FY25 and ₹0.90 in Q1FY25, indicating a decline of 80.0% QoQ and 66.7% YoY.

Operating Metrics

Healthcare Global Enterprises Ltd's operating metrics reflect its financial performance for Q1FY26. Total expenses for the quarter were ₹608.75 crores, marking a 28.0% increase from ₹475.42 crores in Q4FY25, and an 18.1% rise from ₹515.39 crores in Q1FY25. The significant increase in expenses, both quarter-over-quarter and year-over-year, may impact the company's operating margins. These metrics are crucial for understanding the cost structure and resource allocation in the context of the company's operational strategies. The earnings per share (EPS), a critical operating metric, decreased significantly, showcasing the impact of the aforementioned expense increases and reduced profitability on shareholder returns.